Mateusz Ługowik

Mateusz Ługowik is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Gdańsk, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

PCB Bancorp Stock Trades Near 52-Week High Ahead of Friday Close
·

PCB Bancorp Stock Trades Near 52-Week High Ahead of Friday Close

PCB Bancorp was trading at $24.83, up 84 cents, ahead of Friday’s regular session. That move put the Los Angeles-based bank near its 52-week high of $25.15 and valued the company at roughly $354 million. A sharp swing for a small bank stock is getting notice because it comes during a regular U.S. session. This isn’t happening on a holiday or a thin tape—Nasdaq’s calendar shows the next closure is Juneteenth, June 19. Quick moves to yearly highs can draw eyes fast when trading is light.
June 5, 2026
Jowell Global Edges Down in Pre-Market on Light Volume
·

Jowell Global Edges Down in Pre-Market on Light Volume

Jowell Global Ltd. shares fell in the latest U.S. session. The China-focused e-commerce micro-cap stays under pressure ahead of Friday’s Nasdaq open. There was no new company news to explain the drop. The stock finished Thursday at $2.26, slipping 1.31%, according to Yahoo Finance. Shares started the session at $2.23 and moved between $2.20 and $2.36. Just 9,435 shares changed hands. That light volume can swing micro-cap names more in percentage terms.
June 5, 2026
Wise trades sideways after €500 million probe hits market
··

Wise trades sideways after €500 million probe hits market

Wise Group PLC was last seen around 826p early Friday in London. The fintech’s most recent bid-offer was 824p/828p. The FTSE 100 added 0.21% at 10,382.03 in the same session. Wise still trades far off its 1,225p peak for the year and just above its 754p low. Wise is in focus after a sudden hit to its shares, which fell as much as 20% on Monday and ended down 8%. The drop came when the company said it was responding to questions from Belgian prosecutors on money-laundering. The pause comes after this repricing of regulatory risk.
June 5, 2026
Gores Holdings X Edges Higher; GTEN Gets Small Lift
·

Gores Holdings X Edges Higher; GTEN Gets Small Lift

Gores Holdings X Inc. ticked up in recent U.S. trading, holding just over the cash redemption line typical for SPACs yet to secure a deal. Class A shares last traded at $10.43. The Nasdaq-listed units changed hands at $10.49. That small change is important since Gores Holdings X is still a special purpose acquisition company, or SPAC. The shell firm raises money before it has a target, then hunts for a private business to acquire or merge with. At this phase, shares usually stick close to the trust account value — that’s the cash kept aside for a deal, or handed back to investors if nothing gets done.
June 5, 2026
Pyxis Oncology Stock Draws Attention Again After Jefferies as Traders Eye MICVO Results
·

Pyxis Oncology Stock Draws Attention Again After Jefferies as Traders Eye MICVO Results

Shares of Pyxis Oncology ticked higher early Friday as management spoke at the Jefferies Global Healthcare Conference in New York. The company is set to release clinical data from its main program. Pyxis last traded at $1.71, up 3 cents from Thursday’s close, market data showed. Timing is in focus. Pyxis is moving toward a mid-year data update for micvotabart pelidotin in second-line or later recurrent or metastatic head and neck squamous cell carcinoma. That means cancer that's come back or spread after earlier treatment. On its investor site, the company put up a Jefferies fireside chat for June 4 at 7:35 a.m. EDT — a slot that puts management in front of healthcare investors a few weeks before the
June 5, 2026
Old National Bancorp Stock Jumps as Bank Shares Bounce
·

Old National Bancorp Stock Jumps as Bank Shares Bounce

Old National Bancorp shares climbed almost 3% on Thursday as investors turned back to financials in a wider bank stock rally. The Nasdaq-traded stock was recently quoted at $23.97, up 66.5 cents. It traded in a range of $23.43 to $24.07. The market cap was around $9.3 billion, and the P/E ratio stood at 12.4. That put the stock at about 12.4 times annual earnings. Financial stocks carried most of the gains as the U.S. session turned out mixed. The Dow ended up 1.73% at an all-time high, the S&P 500 rose 0.41%, and the Nasdaq lost 0.09%. Reuters reported financials as one of the top S&P 500 sectors. Paul Nolte at Murphy & Sylvest told Reuters that investors were
June 5, 2026
LeMaitre Vascular Shares Rise as Medical-Device Names Gain
·

LeMaitre Vascular Shares Rise as Medical-Device Names Gain

LeMaitre Vascular shares gained 2.0% to $93.56 late Thursday in U.S. trading. The move came with the medical-technology group trading firmer and as traders eyed a planned quarterly dividend from the vascular-device maker. The stock traded in a $92.15 to $95.57 range. Market cap stood around $2.15 billion. LeMaitre's move comes as the company looks to hold investor backing after posting a solid first-quarter report in May. Bigger medical device stocks have seen new buying, too. The iShares U.S. Medical Devices ETF gained 2.8%. That compares to a 0.4% uptick for the SPDR S&P 500 ETF.
June 5, 2026
Janux Therapeutics Shares Tick Up, With Focus Staying on Next Trial Update
·

Janux Therapeutics Shares Tick Up, With Focus Staying on Next Trial Update

Janux Therapeutics shares climbed in late U.S. trading Thursday, finishing the regular Nasdaq session ahead but trailing gains seen across biotech. The stock last traded at $13.76, up 16.5 cents, or roughly 1.2%. It moved between $13.60 and $14.07. The SPDR S&P Biotech ETF climbed 2.7%, while the iShares Nasdaq Biotechnology ETF added 2.3%. Both are ETFs tracking the biotech sector. The Invesco QQQ Trust slipped 0.5%. It tracks bigger Nasdaq growth stocks.
June 5, 2026
Inotiv Stock Slides After Chapter 11 Plan Signals Shareholders at Risk
·

Inotiv Stock Slides After Chapter 11 Plan Signals Shareholders at Risk

Inotiv Inc. shares dropped further into penny-stock range Thursday. The drug-research services firm rolled out a prepackaged Chapter 11 plan that wipes out existing shareholders, offering them no recovery. The stock last changed hands at 8.66 cents, off roughly 28% from where it closed before. Shares moved in a range from 7.79 cents to 11.8 cents. Volume topped 15 million shares.
June 5, 2026
Playtika Slips Again as Investors Look for a Spark
·

Playtika Slips Again as Investors Look for a Spark

Playtika Holding Corp. slipped again Thursday, with the mobile-games group under pressure while most of the wider U.S. market was steadier. Shares on the Nasdaq last changed hands at $3.15, down 5 cents, with around 984,000 shares moved. Playtika is betting that strength in newer games and higher direct-to-consumer sales will balance out the slumps in its older franchises. Direct-to-consumer, or DTC, is when players pay straight through the company’s own channel, instead of mostly using app stores.
June 5, 2026
Neonode Shares Rally for Second Straight Day as Traders Eye Next Move
·

Neonode Shares Rally for Second Straight Day as Traders Eye Next Move

Neonode Inc. shares climbed again Thursday, adding to a midweek surge for the Nasdaq-listed micro-cap. The stock gained while tech shares in general faced pressure. The stock ended the day at $1.85, up 1.65%. Shares changed hands in a range of $1.75 to $1.89. About 125,000 shares traded. Liquidity stayed moderate, which can be an issue for small companies.
June 5, 2026
Youxin Technology Stock Falls Back Below $1 After YAAS Jump — Why Traders Are Watching Now
·

Youxin Technology Stock Falls Back Below $1 After YAAS Jump — Why Traders Are Watching Now

Youxin Technology Ltd shares fell back below $1 on Thursday, giving up part of a sharp prior-day move as trading in the Nasdaq-listed China software microcap stayed thin. Google Finance showed the stock closed at $0.94, down 7.84%, before slipping to $0.91 after hours; it listed volume at 98,480 shares and market value at about $10.6 million. That matters because the move reversed part of Wednesday’s jump. Trading 212 data showed Youxin closed at $1.02 on June 3 after a 14.7% gain, then opened at $1.02 on Thursday and fell as low as $0.87.
June 4, 2026
Flex Shares Lose Steam After AI Rally, Balance Sheet Scrutiny Rises on $1.45 Billion Loan
·

Flex Shares Lose Steam After AI Rally, Balance Sheet Scrutiny Rises on $1.45 Billion Loan

Flex Ltd. shares dropped Thursday, slipping from a recent AI-infrastructure run. The company is taking on a $1.45 billion term loan while it moves more into data-center power systems. Nasdaq had the stock at $159.77, down $2.17, or around 1.3%. Flex has traded between $150.92 and $161.06. Flex’s new financing hits as the company looks to shake its image as a low-margin electronics assembler. In a June 2 SEC filing, Flex said it signed a senior term loan facility on May 29. The loan is fully funded and matures on Nov. 29, 2027.
June 4, 2026
Clearmind Medicine Shares On The Move With Cash Question Looming
·

Clearmind Medicine Shares On The Move With Cash Question Looming

Clearmind Medicine Inc. traded up midday Thursday on Nasdaq. Investors looked at a new financing filing and waited for an update on the company’s lead alcohol-use-disorder study. The micro-cap biotech’s cash levels stayed in focus. The stock gained 1.7% to $2.96, moving between $2.80 and $3.00 so far, with volume at roughly 52,846 shares on the latest feed. The move isn’t big, but for a smaller name, even some light action will shift the price.
June 4, 2026
Osprey Bitcoin Trust Drops With Bitcoin Nears $60,000 Again
·

Osprey Bitcoin Trust Drops With Bitcoin Nears $60,000 Again

Osprey Bitcoin Trust dropped in midday trade Thursday, with Bitcoin holding close to its lowest point in over three months. That kept pressure on listed products linked to the token. OBTC traded at $20.44, off 2.6%, as 13,643 shares changed hands. Bitcoin was sitting near $63,447, down 3.7% for the day, moving between $61,503 and $66,071.
June 4, 2026
NewcelX Stock Moves Up Ahead of FDA Meeting on Diabetes Treatment
·

NewcelX Stock Moves Up Ahead of FDA Meeting on Diabetes Treatment

NewcelX Ltd. shares were slightly up in midday Nasdaq action Thursday, with traders watching the Swiss biotech ahead of its late-June meeting with U.S. regulators on its main cell therapy for type 1 diabetes. The shares traded at $3.18 by 11:47 a.m. EDT, up 2 cents, or 0.6% from the previous close. The session’s range so far has been $3.04 to $3.18. Volume was 13,288 shares at last check.
June 4, 2026
IPOD Stock Is Flat—Why Collective Acquisition’s New CCAQ Tape Still Matters
·

IPOD Stock Is Flat—Why Collective Acquisition’s New CCAQ Tape Still Matters

Collective Acquisition Corp shares were flat at $10.40 in thin Nasdaq trading on Thursday, leaving the former IPOD-linked blank-check company close to its cash-backed level as investors waited for a deal signal. The stock showed volume of 27 shares at 10:04 a.m. EDT, a day range of $10.38 to $10.43 and a market value near $210 million. That matters now because this is not an earnings story in the usual sense. Collective is a SPAC, or special purpose acquisition company, a listed shell that raises money to buy a private business.
June 4, 2026
PolyPid Stock Barely Moves After FDA Filing, But a 2027 Decision Now Looms
·

PolyPid Stock Barely Moves After FDA Filing, But a 2027 Decision Now Looms

PETACH TIKVA, Israel, June 4, 2026, 17:04 IDT PolyPid Ltd. shares edged higher in regular Nasdaq trading on Thursday, a muted move after the Israeli biotech completed its U.S. filing for its lead infection-prevention drug. The stock traded at $4.74, up 0.4%, after opening at $4.72 and moving between $4.69 and $4.74, with volume of about 41,800 shares; Nasdaq’s 2026 calendar lists regular weekday trading and no June 4 market closure.
June 4, 2026
uniQure Stock Rises 12% in Early Trade
·

uniQure Stock Rises 12% in Early Trade

uniQure N.V. shares eased in pre-market trading Thursday, trimming part of Wednesday’s 11.7% jump as traders moved around the Dutch biotech’s uncertain Huntington’s disease gene therapy outlook. The stock ended at $29.88 in the prior session and changed hands at $29.40 ahead of the Nasdaq open at 8:00 a.m. EDT. QURE now trades mostly as a play on AMT-130, its main program for Huntington’s disease. The disease is fatal and inherited. uniQure has been telling investors it plans to file for UK marketing authorization—a request to sell the drug—in the third quarter of 2026, and is also looking for more guidance from U.S. regulators.
June 4, 2026
1 … 21 22 23 24 25 … 39